Coinspeaker GILD Stock Lost 1% Yesterday, Gilead Starts Early-Stage Trial for Its Remdesivir DrugGilead Sciences (GILD) stock is slightly down despite the progress that the company made in testing of its remdesivir drug that can be used as the coronavirus treatment.GILD Stock Lost 1% Yesterday, Gilead Starts Early-Stage Trial for Its Remdesivir Drug